| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000013918 |
| Receipt No. | R000016230 |
| Official scientific title of the study | A prospective randomized controlled multicenter trial of precut and endoscopic ultrasound-guided rendezvous procedure: effect on selective bile duct cannulation in difficult bile duct cannulation using conventional technique |
| Date of disclosure of the study information | 2014/05/09 |
| Last modified on | 2016/06/20 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A prospective randomized controlled multicenter trial of precut and endoscopic ultrasound-guided rendezvous procedure: effect on selective bile duct cannulation in difficult bile duct cannulation using conventional technique | |
| Title of the study (Brief title) | A randomized trials of precut vs EUS-rendezvous | |
| Region |
|
|
| Condition | ||
| Condition | Pancreatobiliary diseases | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the successful biliary cannulation of precut and EUS-rendezvous in patients with difficult cannulation |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Selective biliary cannulation |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Precut | |
| Interventions/Control_2 | EUS-rendezous | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | First time ERCP for biliary cannulation | |||
| Key exclusion criteria | PS4
JCS>1 NYHA III, IV SpO2 < 90% Pregnancy Age <20 Contraindication for endoscopy Pancreatico biliary maljunction Post gastrectomy Acute pancreatitis Chronic pancreatitis Biliary stone impaction Ampullary tumor Previous PTBD Allergy to contrast media |
|||
| Target sample size | 194 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroshi Kawakami |
| Organization | Hokkaido University Graduate School of Medicine |
| Division name | Department of Gastroenterology and Hepatology |
| Address | Kita15, Nishi7, Sapporo, Japan |
| TEL | 011-716-1161 |
| hiropon@med.hokudai.ac.jp | |
| Public contact | |
| Name of contact person | Kazumichi Kawakubo |
| Organization | Hokkaido University Graduate School of Medicine |
| Division name | Department of Gastroenterology and Hepatology |
| Address | Kita15, Nishi7, Sapporo, Japan |
| TEL | 011-716-2111 |
| Homepage URL | |
| kkawakubo-gi@umin.ac.jp | |
| Sponsor | |
| Institute | Department of Gastroenterology and Hepatology |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016230 |